LOGIN  |  REGISTER

Acadia Healthcare to Participate in March Investor Conferences

March 02, 2023 | Last Trade: US$45.06 1.28 2.92

FRANKLIN, Tenn. / Mar 02, 2023 / Business Wire / Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in March.

On Tuesday, March 7, 2023, the Company will participate in the Raymond James 44th Annual Institutional Investors Conference, which is being held March 5 - 8, 2023, in Orlando, Florida. The Company’s presentation will be at 6:30 a.m. Central Time/7:30 a.m. Eastern Time.

On Wednesday, March 8, 2023, the Company will participate in the Cowen 43rd Annual Health Care Conference, to be held March 6 - 8, 2023, in Boston, Massachusetts. The Company’s presentation will be at 9:30 a.m. Central Time/10:30 a.m. Eastern Time.

The live webcast of both presentations will be available on the Company’s website, www.acadiahealthcare.com, by clicking on the “Investors” link. A replay of the presentation will also be available on the Company’s website for 30 days.

About Acadia

Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2022, Acadia operated a network of 250 behavioral healthcare facilities with approximately 11,000 beds in 39 states and Puerto Rico. With approximately 23,000 employees serving more than 75,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

Astria Therapeutics

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page